Viewing Study NCT01081769

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2026-06-02 @ 7:50 AM
Study NCT ID: NCT01081769
Status: COMPLETED
Last Update Posted: 2015-02-18
First Post: 2010-03-04
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
Sponsor: Janssen-Cilag International NV
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Schizophrenia View
None paliperidone palmitate View
None Invega View
None Intramuscular injection View
None Oral antipsychotics View
None Relapse View